The actions of valproate and neurosteroids in a model of trigeminal pain

F. Michael Cutrer, Michael A. Moskowitz

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Gamma-aminobutyric acid (GABA) receptors are ubiquitous inhibitory receptors in the central and peripheral nervous systems. Valproic acid (2- propylpentanoic acid), which enhances GABA synthesis and blocks degradation, is useful in migraine treatment and may act through activation of GABA receptors to modulate trigeminal nociceptive neurons innervating the meninges. To investigate this possibility, we tested the effect of valproate and allopregnanolone, a metabolite of progesterone, which binds and modulates the GABA receptor in an animal model of cephalic pain. One hundred ten Hartley guinea pigs were pretreated with either valproate or allopregnanolone 30 minutes prior to activation of trigeminal afferent fibers via intracisternal injection of the irritant, capsaicin. The effects of valproic acid and allopregnanolone were examined on c-fos expression within the trigeminal nucleus caudalis (lamina I, II0), the termination site for small unmyelinated C fibers projecting from the meninges. C-fos positive cells were counted at three representative levels (rostral, middle, and caudal) by an observer naive to the treatment group. We found that valproate (≤10 mg/kg, IP) reduced labeled cells by 52% (P<0.05) and allopregnanolone (≤100 mg/kg, IP) reduced labeled cells by 42% (P<0.01). Bicuculline (GABA(A) antagonist), but not phaclofen (GABA(B) antagonist), blocked the valproate effect, thereby documenting the importance of GABA(A) receptors. We conclude that the attenuation of c-fos-LI by valproate and allopregnanolone is mediated via GABA(A) receptors. These studies complement prior experiments showing that valproic acid and allopregnanolone block neurogenic inflammation within the meninges via GABA(A) receptor-mediated mechanisms. The findings suggest a potential strategy for discovering new antimigraine drugs with high affinity for the GABA(A) receptor and its modulatory sites.

Original languageEnglish (US)
Pages (from-to)579-585
Number of pages7
JournalHeadache
Volume36
Issue number10
DOIs
StatePublished - Nov 1996
Externally publishedYes

Fingerprint

Valproic Acid
Pregnanolone
GABA Receptors
Neurotransmitter Agents
Pain
Meninges
GABA Antagonists
Neurogenic Inflammation
Trigeminal Nuclei
Unmyelinated Nerve Fibers
Nociceptors
Bicuculline
Irritants
Capsaicin
Peripheral Nervous System
Migraine Disorders
gamma-Aminobutyric Acid
Progesterone
Headache
Guinea Pigs

Keywords

  • allopregnanolone
  • c-fos
  • capsaicin
  • GABA
  • migraine
  • valproate

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

The actions of valproate and neurosteroids in a model of trigeminal pain. / Cutrer, F. Michael; Moskowitz, Michael A.

In: Headache, Vol. 36, No. 10, 11.1996, p. 579-585.

Research output: Contribution to journalArticle

Cutrer, F. Michael ; Moskowitz, Michael A. / The actions of valproate and neurosteroids in a model of trigeminal pain. In: Headache. 1996 ; Vol. 36, No. 10. pp. 579-585.
@article{c1808a1075d547fe80f68b473a659214,
title = "The actions of valproate and neurosteroids in a model of trigeminal pain",
abstract = "Gamma-aminobutyric acid (GABA) receptors are ubiquitous inhibitory receptors in the central and peripheral nervous systems. Valproic acid (2- propylpentanoic acid), which enhances GABA synthesis and blocks degradation, is useful in migraine treatment and may act through activation of GABA receptors to modulate trigeminal nociceptive neurons innervating the meninges. To investigate this possibility, we tested the effect of valproate and allopregnanolone, a metabolite of progesterone, which binds and modulates the GABA receptor in an animal model of cephalic pain. One hundred ten Hartley guinea pigs were pretreated with either valproate or allopregnanolone 30 minutes prior to activation of trigeminal afferent fibers via intracisternal injection of the irritant, capsaicin. The effects of valproic acid and allopregnanolone were examined on c-fos expression within the trigeminal nucleus caudalis (lamina I, II0), the termination site for small unmyelinated C fibers projecting from the meninges. C-fos positive cells were counted at three representative levels (rostral, middle, and caudal) by an observer naive to the treatment group. We found that valproate (≤10 mg/kg, IP) reduced labeled cells by 52{\%} (P<0.05) and allopregnanolone (≤100 mg/kg, IP) reduced labeled cells by 42{\%} (P<0.01). Bicuculline (GABA(A) antagonist), but not phaclofen (GABA(B) antagonist), blocked the valproate effect, thereby documenting the importance of GABA(A) receptors. We conclude that the attenuation of c-fos-LI by valproate and allopregnanolone is mediated via GABA(A) receptors. These studies complement prior experiments showing that valproic acid and allopregnanolone block neurogenic inflammation within the meninges via GABA(A) receptor-mediated mechanisms. The findings suggest a potential strategy for discovering new antimigraine drugs with high affinity for the GABA(A) receptor and its modulatory sites.",
keywords = "allopregnanolone, c-fos, capsaicin, GABA, migraine, valproate",
author = "Cutrer, {F. Michael} and Moskowitz, {Michael A.}",
year = "1996",
month = "11",
doi = "10.1046/j.1526-4610.1996.3610579.x",
language = "English (US)",
volume = "36",
pages = "579--585",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - The actions of valproate and neurosteroids in a model of trigeminal pain

AU - Cutrer, F. Michael

AU - Moskowitz, Michael A.

PY - 1996/11

Y1 - 1996/11

N2 - Gamma-aminobutyric acid (GABA) receptors are ubiquitous inhibitory receptors in the central and peripheral nervous systems. Valproic acid (2- propylpentanoic acid), which enhances GABA synthesis and blocks degradation, is useful in migraine treatment and may act through activation of GABA receptors to modulate trigeminal nociceptive neurons innervating the meninges. To investigate this possibility, we tested the effect of valproate and allopregnanolone, a metabolite of progesterone, which binds and modulates the GABA receptor in an animal model of cephalic pain. One hundred ten Hartley guinea pigs were pretreated with either valproate or allopregnanolone 30 minutes prior to activation of trigeminal afferent fibers via intracisternal injection of the irritant, capsaicin. The effects of valproic acid and allopregnanolone were examined on c-fos expression within the trigeminal nucleus caudalis (lamina I, II0), the termination site for small unmyelinated C fibers projecting from the meninges. C-fos positive cells were counted at three representative levels (rostral, middle, and caudal) by an observer naive to the treatment group. We found that valproate (≤10 mg/kg, IP) reduced labeled cells by 52% (P<0.05) and allopregnanolone (≤100 mg/kg, IP) reduced labeled cells by 42% (P<0.01). Bicuculline (GABA(A) antagonist), but not phaclofen (GABA(B) antagonist), blocked the valproate effect, thereby documenting the importance of GABA(A) receptors. We conclude that the attenuation of c-fos-LI by valproate and allopregnanolone is mediated via GABA(A) receptors. These studies complement prior experiments showing that valproic acid and allopregnanolone block neurogenic inflammation within the meninges via GABA(A) receptor-mediated mechanisms. The findings suggest a potential strategy for discovering new antimigraine drugs with high affinity for the GABA(A) receptor and its modulatory sites.

AB - Gamma-aminobutyric acid (GABA) receptors are ubiquitous inhibitory receptors in the central and peripheral nervous systems. Valproic acid (2- propylpentanoic acid), which enhances GABA synthesis and blocks degradation, is useful in migraine treatment and may act through activation of GABA receptors to modulate trigeminal nociceptive neurons innervating the meninges. To investigate this possibility, we tested the effect of valproate and allopregnanolone, a metabolite of progesterone, which binds and modulates the GABA receptor in an animal model of cephalic pain. One hundred ten Hartley guinea pigs were pretreated with either valproate or allopregnanolone 30 minutes prior to activation of trigeminal afferent fibers via intracisternal injection of the irritant, capsaicin. The effects of valproic acid and allopregnanolone were examined on c-fos expression within the trigeminal nucleus caudalis (lamina I, II0), the termination site for small unmyelinated C fibers projecting from the meninges. C-fos positive cells were counted at three representative levels (rostral, middle, and caudal) by an observer naive to the treatment group. We found that valproate (≤10 mg/kg, IP) reduced labeled cells by 52% (P<0.05) and allopregnanolone (≤100 mg/kg, IP) reduced labeled cells by 42% (P<0.01). Bicuculline (GABA(A) antagonist), but not phaclofen (GABA(B) antagonist), blocked the valproate effect, thereby documenting the importance of GABA(A) receptors. We conclude that the attenuation of c-fos-LI by valproate and allopregnanolone is mediated via GABA(A) receptors. These studies complement prior experiments showing that valproic acid and allopregnanolone block neurogenic inflammation within the meninges via GABA(A) receptor-mediated mechanisms. The findings suggest a potential strategy for discovering new antimigraine drugs with high affinity for the GABA(A) receptor and its modulatory sites.

KW - allopregnanolone

KW - c-fos

KW - capsaicin

KW - GABA

KW - migraine

KW - valproate

UR - http://www.scopus.com/inward/record.url?scp=0030277221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030277221&partnerID=8YFLogxK

U2 - 10.1046/j.1526-4610.1996.3610579.x

DO - 10.1046/j.1526-4610.1996.3610579.x

M3 - Article

VL - 36

SP - 579

EP - 585

JO - Headache

JF - Headache

SN - 0017-8748

IS - 10

ER -